FDA inspection
Smith & Nephew Inc.: FDA inspection ending Sep 30, 2022
FDA inspection 1182237 · Voluntary Action Indicated (VAI) · Fort Worth, TX
Key facts
| Inspection ID | 1182237 |
|---|---|
| Firm | Smith & Nephew Inc. |
| FEI number | 3011034132 |
| Address | 4900 W Vickery Blvd |
| City | Fort Worth |
| State | TX |
| ZIP | 76107-7290 |
| Fiscal year | 2022 |
| Inspection end date | Sep 30, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data